EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Efficacy and Safety of the Individual Batroxobin Strategy in Treating Cerebral Venous Thrombosis: An Obstervational Study

Duo Lan, Xiangqian Huang, Xiaoming Zhang, Rong Wang, Mengqi Wang, Zhongao Wang, Yibing Guo, Da Zhou, Ran Meng iD

Clinical and Applied Thrombosis/Hemostasis · 2025

DOI: 10.1177/10760296251400697 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2025. Verfasst von Duo Lan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Venous Thrombosis, Intracranial Thrombosis, Batroxobin. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies have demonstrated the potential benefits of the routine use of batroxobin in treating cerebral venous thrombosis (CVT). However, there is still a need to discuss how to achieve maximum clinical effectiveness when using batroxobin for CVT correction. Therefore, this study aimed to analyze the efficacy and safety of individualized batroxobin strategies in treating CVT.

Methods

This observational clinical study analyzed data from 41 patients with acute CVT. The patients were divided into two groups based on their batroxobin treatment strategies: the individualized group (batroxobin used more than 5 times, n = 16) and the standard group (batroxobin used 3 times, n = 25). The degree of recanalization and attenuation of segmental stenosis were analyzed using MRBTI. The incidence of bleeding events was also analyzed.

Results

The individualized group had significantly higher odds of achieving recanalization (14/16) [adjusted OR (95%CI) of 2.96 (1.30-6.71)] and greater attenuation of segmental stenosis [adjusted OR (95%CI) of 2.16 (1.04-4.49)] compared to the standard group (17/25). There was no statistically significant difference in the incidence of bleeding events between the individualized and standard groups (P > 0.05).

Conclusions

This observational study suggests that an individualized batroxobin strategy may be more effective than the standard approach in promoting cerebral venous thrombosis (CVT) recanalization and reducing CVT-induced stenosis. Further clinical trials are needed to confirm the potential benefits of this individualized therapeutic strategy.

Trial registration

This study protocol was reviewed and approved by the ethics committee of Xuanwu Hospital, Capital Medical University (No. 2022-004, dated on November 20, 2022). The clinical trial was registered at Chinese Clinical Trial Registry (ChiCTR2200057621).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThrombosisIntracranial ThrombosisBatroxobinHumansMaleFemaleAdultMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

anticoagulationbatroxobincerebral venous thrombosisindividualthrombolysis

Substanzen

Batroxobin

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Advanced Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.
  • Department of Echocardiography, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Ran Meng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lan, D., Huang, X., Zhang, X., Wang, R., Wang, M., Wang, Z., Guo, Y., Zhou, D., & Meng, R. (2025). Efficacy and Safety of the Individual Batroxobin Strategy in Treating Cerebral Venous Thrombosis: An Obstervational Study. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296251400697

Vancouver

Lan D, Huang X, Zhang X, Wang R, Wang M, Wang Z, et al. Efficacy and Safety of the Individual Batroxobin Strategy in Treating Cerebral Venous Thrombosis: An Obstervational Study. Clinical and Applied Thrombosis/Hemostasis. 2025. doi:10.1177/10760296251400697

BibTeX
@article{Lan2025,
  author = {Lan, Duo and Huang, Xiangqian and Zhang, Xiaoming and Wang, Rong and Wang, Mengqi and Wang, Zhongao and Guo, Yibing and Zhou, Da and Meng, Ran},
  title = {Efficacy and Safety of the Individual Batroxobin Strategy in Treating Cerebral Venous Thrombosis: An Obstervational Study},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2025},
  doi = {10.1177/10760296251400697}
}
Kostenlos starten →